Tin tức & Cập nhật
Lọc theo Chuyên ngành:

Antidepressant combos deliver improved outcomes in TRD
Combination treatment with esketamine plus either a selective serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI) is beneficial in treatment-resistant depression (TRD), with notable variations in outcomes depending on the choice of antidepressant class, as shown in a large retrospective study.
Antidepressant combos deliver improved outcomes in TRD
06 Apr 2025
Is vitiligo as side effect a good sign for cancer patients on immunotherapy?
Vitiligo occurs as a cutaneous immune-related adverse event during immune checkpoint inhibitor (ICI) therapy in most melanoma and nonmelanoma cancer patients with partial or complete response to treatment, according to a systematic review.
Is vitiligo as side effect a good sign for cancer patients on immunotherapy?
03 Apr 2025
Tirzepatide lowers HbA1c, body weight in adults with T2D
Treatment with tirzepatide once weekly results in significant decreases in glycated haemoglobin A1c (HbA1c) and body weight (BW), regardless of antiglutamic acid decarboxylase autoantibodies (GADA) status in adults with type 2 diabetes (T2D), according to a post hoc analysis of SURPASS.
Tirzepatide lowers HbA1c, body weight in adults with T2D
01 Apr 2025
Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
In the absence of infant hepatitis B immune globulin (HBIg), maternal tenofovir disoproxil fumarate (TDF) prophylaxis combined with infant hepatitis B virus (HBV) immunization provide sufficient protection against HBV infection in infants, findings from the iTAP-2 study suggest. However, the risk of infection was not demonstrably below 2 percent.